{
    "code": "56025256",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56025256",
    "time": "2020-02-26 07:21:50",
    "許可證字號": "衛部醫器輸字第025256號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/08\/07",
    "發證日期": "102\/08\/07",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA05602525602",
    "中文品名": "希摩西爾未分段肝素品管液",
    "英文品名": "HemosIL UF Heparin Controls",
    "效能": "本產品搭配IL血液凝固儀器系統(ACL TOP系列、ACL ELITE\/ELITE PRO\/8\/9\/10000、及ACL Futura\/ACL Advance)，當作液態肝素試劑的未分段肝素(unfractionated heparin, UFH)品管使用。",
    "醫器規格": "0020300300\r\n以下空白",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "B血液學及病理學裝置",
    "醫器主類別二": [
        ""
    ],
    "醫器主類別三": "",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "640110B420  台灣沃芬有限公司",
        "申請商地址": "臺北市內湖區堤頂大道二段501號4樓",
        "主製造廠": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560252560001-103-01-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56025256&Seq=001&Type=9"
        },
        {
            "title": "560252560002-103-01-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56025256&Seq=001&Type=8"
        }
    ]
}